Monitor the outcome of Resolution 3 (increased placement capacity) and Resolution 4 (Omnibus Plan renewal) at the AGM. Approval would grant the board additional flexibility to issue equity, potentially dilutive. The board's opposition to Resolution 5 suggests a contested director election, which may signal governance tension.
Price Chart
Executive Summary
Immuron filed its Notice of 2026 Annual General Meeting and Proxy Form as a 6-K. The AGM will be held on 18 November 2026. Key proposals include the adoption of the remuneration report, re-election of director Dr. Jeannette Joughin, approval of an increased placement capacity (up to 10% of issued capital under ASX Listing Rule 7.1A), renewal of the Omnibus Incentive Plan, and the election of a non-board endorsed director candidate, Mr. Param Lally, which the Board recommends against. The filing is routine governance and contains no material financial data or operational updates.
Key Facts
- AGM scheduled for 18 November 2026 at 2:00 pm AEDT.
- Resolution 3 seeks approval for a 10% placement facility under ASX Listing Rule 7.1A.
- Resolution 4 seeks renewal of the Omnibus Incentive Plan with a 12.5% cap over 3 years.
- Resolution 5 involves the election of non-board endorsed candidate Mr. Param Lally; Board recommends voting AGAINST.
- The company has issued 26,821,997 equity securities under Listing Rule 7.1A in the past 12 months.
- No material financial figures (revenue, EPS, cash flow) are disclosed in this filing.
Financial Impact
No financial impact from this filing; it is a routine AGM notice with governance resolutions.
Risk Factors
- Potential dilution if Resolution 3 is approved and the company issues shares under the 10% placement facility.
- Shareholder rejection of the remuneration report could trigger a 'first strike' under Australian law.
- Election of Mr. Lally against board recommendation could indicate shareholder dissatisfaction with current board composition.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-110026 |
| Document: ea0308834-6k_immuron.htm | 0001213900-26-110026 |
| Document: 0001213900-26-110026-index-headers.html | 0001213900-26-110026 |
| Document: 0001213900-26-110026-index.html | 0001213900-26-110026 |
| Document: 0001213900-26-110026.txt | 0001213900-26-110026 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 6-K | $0.9320 | awaiting T+60 | — | $0.9200 (−1.29%) |
Oct 23, 2026 3d ago | 424B5 | $0.9320 | awaiting T+60 | — | $0.9200 (−1.29%) |
Oct 21, 2026 4d ago | 6-K | $0.9490 | awaiting T+60 | — | $0.9200 (−3.06%) |
Oct 16, 2026 10d ago | 6-K | $0.9821 | awaiting T+60 | — | $0.9200 (−6.32%) |
Oct 13, 2026 13d ago | 6-K | $1.04 | awaiting T+60 | — | $0.9200 (−11.54%) |
Sep 24, 2026 4w ago | 20-F | $1.19 | awaiting T+60 | — | $0.9200 (−22.69%) |
Sep 24, 2026 4w ago | 6-K | $1.19 | awaiting T+60 | — | $0.9200 (−22.69%) |
Sep 21, 2026 4w ago | 6-K | $1.26 | awaiting T+60 | — | $0.9200 (−26.69%) |
Sep 4, 2026 7w ago | Press Release | $1.80 | awaiting T+60 | — | $0.9200 (−48.89%) |
Aug 28, 2026 8w ago | 6-K | $1.15 | awaiting T+60 | — | $0.9200 (−20.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers